About
JaxBio aims to change the way cancer is diagnosed and managed, with a simple and sensitive blood test. This test will enable early detection, monitoring of disease status, and predicting response to therapy. The company has developed an ultra-sensitive method to detect genetic and epigenetic profiles in cell-free DNA, that occur during cancer initiation and progression. It extracts cell-free DNA from a blood sample and fluorescently label markers utilizing a proprietary process. The DNA is hybridized onto a custom chip, and each cancer type presents a unique pixel pattern signature that may be used for classifying the type and stage of the disease.
JaxBio is currently focused on developing its first diagnostic tests for lung cancer and hematological malignancies.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is JaxBio Technologies' primary focus?
- JaxBio Technologies is developing a simple and sensitive blood test for early cancer diagnosis, monitoring disease status, and predicting therapy response.
- When was JaxBio Technologies founded?
- JaxBio Technologies was founded in January 2022.
- How many employees does JaxBio Technologies currently have?
- JaxBio Technologies currently has 13 employees.
- What is the total amount of funding JaxBio Technologies has raised?
- JaxBio Technologies has raised a total of $17,980,000 USD.
- Which types of cancer are JaxBio Technologies' initial diagnostic tests focused on?
- JaxBio Technologies is currently focused on developing its first diagnostic tests for lung cancer and hematological malignancies.
- What grant did JaxBio Technologies secure in July 2024?
- In July 2024, JaxBio Technologies secured a €2.5M grant from the European Innovation Council Accelerator.
- What grant did JaxBio Technologies receive in January 2023?
- In January 2023, JaxBio Technologies received a €8.5M grant from the European Innovation Council to support the creation of array-based cancer tests.
- Where is JaxBio Technologies headquartered?
- JaxBio Technologies is headquartered in Netanya, Israel.
- How does JaxBio Technologies' technology work?
- JaxBio Technologies uses an ultra-sensitive method to detect genetic and epigenetic profiles in cell-free DNA from blood samples. This DNA is fluorescently labeled, hybridized onto a custom chip, and then analyzed for unique pixel pattern signatures to classify cancer type and stage.